Transvenous liver biopsy

Ilan S. Weisberg, Samuel H. Sigal, Robert S. Brown

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Interpretation of liver biopsy findings serves as the foundation for the understanding and treatment of liver diseases. Despite rapidly improving molecular, biochemical, and serologic testing, liver biopsy remains the diagnostic gold standard. Histologic assessment provides critical prognostic information and is frequently pivotal in therapeutic decisions. For most individuals, liver biopsy is safely and efficiently performed by the standard percutaneous approach. However, in patients with advanced liver disease, for whom liver biopsy findings may be most critical, bleeding complications after invasive procedure such as a percutaneous liver biopsy can be associated with unacceptable risk. Alternatives for this group have included open or laparoscopic liver biopsy, transjugular liver biopsy (TJLB) or empiric treatment without histology. Of these TJLB provides the least invasive method to obtain reasonable diagnostic material. TJLB has been safely and successfully performed for the past 40 years. Until recently, however, TJLB has been limited by relatively small size of the core liver sample, leading to frequently uninterpretable histologic results. However, greatly improved tissue sampling is now achieved with increased technical experience, incorporation of better radiologic imaging, and improvements in the biopsy needle. In this chapter we review the development of the transjugular liver biopsy, with particular emphasis on the safety and efficacy of this technology, and discuss its role in special patient populations such as children, fulminant hepatitis, and liver transplant recipients.

Original languageEnglish (US)
Title of host publicationClinical Hepatology: Principles and Practice of Hepatobiliary Diseases
PublisherSpringer Berlin Heidelberg
Pages473-484
Number of pages12
ISBN (Print)9783642045097
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Biopsy
Liver
Liver Diseases
Needle Biopsy
Hepatitis
Histology
Therapeutics
Hemorrhage
Technology
Safety
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Weisberg, I. S., Sigal, S. H., & Brown, R. S. (2010). Transvenous liver biopsy. In Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases (pp. 473-484). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-93842-2_44

Transvenous liver biopsy. / Weisberg, Ilan S.; Sigal, Samuel H.; Brown, Robert S.

Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. Springer Berlin Heidelberg, 2010. p. 473-484.

Research output: Chapter in Book/Report/Conference proceedingChapter

Weisberg, IS, Sigal, SH & Brown, RS 2010, Transvenous liver biopsy. in Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. Springer Berlin Heidelberg, pp. 473-484. https://doi.org/10.1007/978-3-540-93842-2_44
Weisberg IS, Sigal SH, Brown RS. Transvenous liver biopsy. In Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. Springer Berlin Heidelberg. 2010. p. 473-484 https://doi.org/10.1007/978-3-540-93842-2_44
Weisberg, Ilan S. ; Sigal, Samuel H. ; Brown, Robert S. / Transvenous liver biopsy. Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. Springer Berlin Heidelberg, 2010. pp. 473-484
@inbook{d4817b5481434c80af8fa2b39c1821ec,
title = "Transvenous liver biopsy",
abstract = "Interpretation of liver biopsy findings serves as the foundation for the understanding and treatment of liver diseases. Despite rapidly improving molecular, biochemical, and serologic testing, liver biopsy remains the diagnostic gold standard. Histologic assessment provides critical prognostic information and is frequently pivotal in therapeutic decisions. For most individuals, liver biopsy is safely and efficiently performed by the standard percutaneous approach. However, in patients with advanced liver disease, for whom liver biopsy findings may be most critical, bleeding complications after invasive procedure such as a percutaneous liver biopsy can be associated with unacceptable risk. Alternatives for this group have included open or laparoscopic liver biopsy, transjugular liver biopsy (TJLB) or empiric treatment without histology. Of these TJLB provides the least invasive method to obtain reasonable diagnostic material. TJLB has been safely and successfully performed for the past 40 years. Until recently, however, TJLB has been limited by relatively small size of the core liver sample, leading to frequently uninterpretable histologic results. However, greatly improved tissue sampling is now achieved with increased technical experience, incorporation of better radiologic imaging, and improvements in the biopsy needle. In this chapter we review the development of the transjugular liver biopsy, with particular emphasis on the safety and efficacy of this technology, and discuss its role in special patient populations such as children, fulminant hepatitis, and liver transplant recipients.",
author = "Weisberg, {Ilan S.} and Sigal, {Samuel H.} and Brown, {Robert S.}",
year = "2010",
doi = "10.1007/978-3-540-93842-2_44",
language = "English (US)",
isbn = "9783642045097",
pages = "473--484",
booktitle = "Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Transvenous liver biopsy

AU - Weisberg, Ilan S.

AU - Sigal, Samuel H.

AU - Brown, Robert S.

PY - 2010

Y1 - 2010

N2 - Interpretation of liver biopsy findings serves as the foundation for the understanding and treatment of liver diseases. Despite rapidly improving molecular, biochemical, and serologic testing, liver biopsy remains the diagnostic gold standard. Histologic assessment provides critical prognostic information and is frequently pivotal in therapeutic decisions. For most individuals, liver biopsy is safely and efficiently performed by the standard percutaneous approach. However, in patients with advanced liver disease, for whom liver biopsy findings may be most critical, bleeding complications after invasive procedure such as a percutaneous liver biopsy can be associated with unacceptable risk. Alternatives for this group have included open or laparoscopic liver biopsy, transjugular liver biopsy (TJLB) or empiric treatment without histology. Of these TJLB provides the least invasive method to obtain reasonable diagnostic material. TJLB has been safely and successfully performed for the past 40 years. Until recently, however, TJLB has been limited by relatively small size of the core liver sample, leading to frequently uninterpretable histologic results. However, greatly improved tissue sampling is now achieved with increased technical experience, incorporation of better radiologic imaging, and improvements in the biopsy needle. In this chapter we review the development of the transjugular liver biopsy, with particular emphasis on the safety and efficacy of this technology, and discuss its role in special patient populations such as children, fulminant hepatitis, and liver transplant recipients.

AB - Interpretation of liver biopsy findings serves as the foundation for the understanding and treatment of liver diseases. Despite rapidly improving molecular, biochemical, and serologic testing, liver biopsy remains the diagnostic gold standard. Histologic assessment provides critical prognostic information and is frequently pivotal in therapeutic decisions. For most individuals, liver biopsy is safely and efficiently performed by the standard percutaneous approach. However, in patients with advanced liver disease, for whom liver biopsy findings may be most critical, bleeding complications after invasive procedure such as a percutaneous liver biopsy can be associated with unacceptable risk. Alternatives for this group have included open or laparoscopic liver biopsy, transjugular liver biopsy (TJLB) or empiric treatment without histology. Of these TJLB provides the least invasive method to obtain reasonable diagnostic material. TJLB has been safely and successfully performed for the past 40 years. Until recently, however, TJLB has been limited by relatively small size of the core liver sample, leading to frequently uninterpretable histologic results. However, greatly improved tissue sampling is now achieved with increased technical experience, incorporation of better radiologic imaging, and improvements in the biopsy needle. In this chapter we review the development of the transjugular liver biopsy, with particular emphasis on the safety and efficacy of this technology, and discuss its role in special patient populations such as children, fulminant hepatitis, and liver transplant recipients.

UR - http://www.scopus.com/inward/record.url?scp=84892349418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892349418&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-93842-2_44

DO - 10.1007/978-3-540-93842-2_44

M3 - Chapter

SN - 9783642045097

SP - 473

EP - 484

BT - Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases

PB - Springer Berlin Heidelberg

ER -